Setting Realistic Growth Goals for Your Allergy Practice This Year

Vague growth intentions are not a plan, allergy practices that set specific, measurable new-patient targets and align their operations to reach them consistently outperform peers who rely on word of mouth and seasonal demand alone.

Why "We Want to Grow" Is Not a Goal

The start of a new year invites optimism, and it is common for practice leaders to set intentions like "grow our patient base" or "increase revenue." These statements describe a direction, not a destination. Without a number attached to a timeframe, there is no way to assess progress, allocate resources, or know when something is working.

Realistic growth goals begin with specificity. For an allergy and immunology practice, new-patient volume is the most direct lever to pull. A stated goal of adding 20 net-new patients per month by the third quarter is concrete enough to plan around: it informs hiring decisions, scheduling templates, marketing spend, and referral outreach targets. Vague intent does not.

The discipline of setting measurable goals also creates accountability. When a target exists, the practice can evaluate whether each marketing initiative, referral relationship, or operational change is contributing to it, or not.

Benchmark Against Your Own Baseline First

Before projecting forward, it is essential to understand where the practice actually stands. Pull a full-year report of new-patient visits from your practice management system, broken down by month. Most allergy practices will immediately see a pronounced seasonal curve: volume rises through spring pollen season and into fall ragweed season, then drops sharply in winter.

That baseline is the foundation. A realistic growth target accounts for the seasonality rather than ignoring it. Setting a flat monthly new-patient target of 60 when the practice historically sees 90 in May and 35 in January creates unnecessary anxiety in winter and false confidence in spring. Instead, apply a growth percentage, say, 15 percent above last year, to each month's historical number. The resulting monthly targets will be uneven, and that is correct.

This approach also helps distinguish genuine growth from seasonal noise. A practice that sees strong January numbers should ask whether it is actually acquiring more patients or simply filling residual demand from a patient-short prior fall.

Define the Right Growth Metrics Beyond New Patients

New-patient volume is primary, but it is not the only number worth tracking. For practices offering immunotherapy programs, subcutaneous allergy shots or sublingual drops, the number of patients actively in treatment is a more stable revenue indicator than new-patient visits alone. Immunotherapy patients visit weekly or biweekly for months or years; growth in this population compounds in a way that a single new-patient appointment does not.

Practices with biologics programs for severe asthma or chronic urticaria should similarly track the number of patients currently on therapy. A patient receiving dupilumab or omalizumab generates ongoing clinical visits and requires close monitoring, making that panel size a meaningful growth metric separate from standard new-patient counts.

Return visits and the ratio of new-to-established patients also matter. A practice that is growing new patients but losing established patients to attrition, because follow-up communication is poor or wait times have lengthened, may not be growing at all in net terms.

Set Referral Targets Alongside Patient Targets

The dominant source of new allergy patients in most markets remains the primary care referral. Allergists who treat referral relationships as passive, assuming PCPs will send patients when appropriate, typically see slower, less predictable new-patient growth than those who actively cultivate those relationships.

A concrete referral goal gives the practice something to work toward: for example, establishing or deepening relationships with ten new primary care practices in the calendar year. This translates into actions, scheduling lunch-and-learns, sending clinical update letters when a shared patient completes immunotherapy, calling the PCP directly after an asthma hospitalization. Those behaviors can be tracked in a simple CRM or even a spreadsheet.

It is also worth analyzing current referral patterns to find concentration risk. If 40 percent of new patients come from two PCP groups, a change in either group's staffing or ownership could materially affect the practice. Growth goals should include diversifying the referral source mix, not just increasing total volume.

Tie Digital Presence Goals to Patient Targets

In consumer-driven healthcare, a meaningful share of patients now self-refer or arrive having already researched their options before a PCP recommendation is made. A patient told to "see an allergist" often searches online before calling any number on a referral slip. This means the practice's digital presence is part of the growth equation.

Specific digital goals that connect to new-patient targets include: achieving a rating threshold on Google and Healthgrades (a sustained 4.5 or higher is a reasonable benchmark), increasing the volume of recent reviews through a systematic post-visit follow-up process, and ensuring the practice appears correctly in every relevant directory, Google Business Profile, Zocdoc, insurance-carrier finders, and local hospital referral networks.

Practices should also audit their website for basic usability. If a patient cannot determine, within ten seconds of landing on the practice homepage, what conditions are treated, whether new patients are being accepted, and how to request an appointment, the site is likely losing patients who found it. These are correctable problems that do not require large budgets.

Account for Capacity Constraints Before Setting Targets

A growth goal that exceeds the practice's capacity to deliver care is not a goal, it is a setup for burnout, poor patient experience, and reputation damage. Before committing to a new-patient target, practice leaders should assess the current schedule honestly: How many new-patient slots open per week? What is the current new-patient wait time?

If the existing wait time already exceeds two weeks, adding volume without adding capacity will extend waits further, generating negative reviews and PCP frustration that undermines the very growth being sought. The growth goal may therefore need to begin with operational improvements, adding a provider, restructuring scheduling templates, or expanding allergy testing hours, before a meaningful new-patient target can be pursued.

Nurse practitioners and physician assistants, where scope of practice allows, can meaningfully expand immunotherapy management and follow-up capacity, freeing physicians to see more new patients. This kind of capacity planning belongs in the growth conversation from the start.

Build in Quarterly Review Points

Annual goals set in January have a poor track record of remaining relevant through December. Markets shift, a key PCP retires mid-year, an unexpected biologic approval changes the referral landscape, or a competing practice opens nearby. The goal itself needs to be reviewed, not just the progress toward it.

Scheduling a formal quarterly review, not a casual glance at a dashboard, but a deliberate meeting reviewing actual versus target across every metric, creates the rhythm that makes annual goals useful. The first quarter review, typically in April, arrives just as spring allergy season is ramping and gives the practice a chance to respond quickly if new-patient numbers are tracking below plan.

These reviews should examine leading indicators alongside lagging ones. New-patient visits are a lagging measure, they reflect decisions and referrals made weeks earlier. Active referral conversations, recent reviews posted, and new PCP relationships established are leading indicators that predict whether the pipeline is healthy.

Patient Portal and Communication Infrastructure

Practices targeting meaningful growth will increasingly find that patient communication infrastructure affects their ability to retain the patients they acquire. A patient who completes allergy testing, begins immunotherapy, and then finds it difficult to communicate with the office about shot schedules or medication questions is a departure risk and a reputational liability.

Patient portals, when actually used by patients and staff, reduce phone volume and create a documented communication trail that improves care coordination. Setting a usage adoption target, for example, reaching 50 percent of active immunotherapy patients using the portal for appointment confirmations, is a practical goal that ties practice technology investment to real outcomes.

Automated appointment reminders for allergy shot visits also directly affect immunotherapy adherence, which in turn affects whether patients complete their treatment course and generate the word-of-mouth and physician goodwill that powers organic growth.

Involve the Full Team in the Plan

Growth goals owned only by the physician-owner or practice administrator rarely get realized. The front desk team is the first point of contact for referral calls and new-patient inquiries; if they do not understand the growth targets or feel invested in them, conversion rates suffer. Clinical staff who understand that the practice is actively growing its immunotherapy panel will naturally be more alert to opportunities to introduce the program to appropriate patients.

Brief, regular all-staff updates on how the practice is tracking against goals, without turning every team meeting into a performance review, create shared purpose. The goal is not to pressure staff but to connect their daily work to outcomes that are visible and meaningful.

Looking Ahead

The practices that will look back on 2022 as a successful growth year will likely share a common discipline: they began with a specific plan, measured against it consistently, and adjusted when circumstances changed. Consumer expectations in healthcare continue to shift toward convenience, transparency, and digital accessibility. Practices that respond to those expectations, with clear online information, responsive communication, manageable wait times, and a strong reputation, are better positioned regardless of the precise growth number they set.

Setting realistic goals is not a limiting exercise. It is the precondition for taking genuine, measurable steps forward, and for knowing, at year's end, whether those steps worked.